AI assistant
Sending…
MADRIGAL PHARMACEUTICALS, INC. — Director's Dealing 2021
May 19, 2021
30608_dirs_2021-05-19_309594d1-a0eb-4441-b6f9-feb38d19b0e2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK: 0001157601
Period of Report: 2021-05-17
Reporting Person: Howarth Alex G. (Chief Financial Officer)
More from MADRIGAL PHARMACEUTICALS, INC.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 24
Annual Report
2026
Feb 19
Regulatory Filings
2026
Feb 19
Regulatory Filings
2026
Jan 30
Director's Dealing
2026
Jan 26